Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

752 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Beriberi heart failure caused by a retort pouch diet menu].
Ishikawa Y, Miyagi M, Matsumoto T, Watanabe N, Tojo Y, Hiroi N, Kuboki K, Yoshino G, Tsubota T, Yoshihara K. Ishikawa Y, et al. Among authors: miyagi m. Nihon Naika Gakkai Zasshi. 2008 Oct 10;97(10):2552-4. doi: 10.2169/naika.97.2552. Nihon Naika Gakkai Zasshi. 2008. PMID: 19051749 Japanese. No abstract available.
Acute focal bacterial nephritis in an occupational allergy.
Iga R, Uchino H, Kanazawa K, Usui S, Miyagi M, Kumashiro N, Hirose T. Iga R, et al. Among authors: miyagi m. Lancet Infect Dis. 2014 Jul;14(7):656. doi: 10.1016/S1473-3099(14)70738-8. Lancet Infect Dis. 2014. PMID: 24964943 No abstract available.
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan.
Tateishi R, Matsumura T, Okanoue T, Shima T, Uchino K, Fujiwara N, Senokuchi T, Kon K, Sasako T, Taniai M, Kawaguchi T, Inoue H, Watada H, Kubota N, Shimano H, Kaneko S, Hashimoto E, Watanabe S, Shiota G, Ueki K, Kashiwabara K, Matsuyama Y, Tanaka H, Kasuga M, Araki E, Koike K; LUCID study investigators. Tateishi R, et al. J Gastroenterol. 2021 Mar;56(3):261-273. doi: 10.1007/s00535-020-01754-z. Epub 2021 Jan 11. J Gastroenterol. 2021. PMID: 33427937 Free PMC article.
Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium-glucose cotransporter 2 inhibitor: A randomized, open-label, prospective study.
Kanazawa K, Uchino H, Shigiyama F, Igarashi H, Ikehara K, Yoshikawa F, Usui S, Miyagi M, Yoshino H, Ando Y, Kumashiro N, Hirose T. Kanazawa K, et al. Among authors: miyagi m. J Diabetes Investig. 2019 Jul;10(4):1022-1031. doi: 10.1111/jdi.12994. Epub 2019 Feb 19. J Diabetes Investig. 2019. PMID: 30582774 Free PMC article. Clinical Trial.
Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm.
Miyagi M, Uchino H, Kumashiro N, Higa M, Shin K, Sasamoto M, Kitazato H, Tamaki M, Matsuhisa M, Hirose T. Miyagi M, et al. Diabetes Ther. 2018 Oct;9(5):1959-1968. doi: 10.1007/s13300-018-0486-1. Epub 2018 Aug 18. Diabetes Ther. 2018. PMID: 30121725 Free PMC article.
Efficacy of intermittent empagliflozin supplementation on dietary self-management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24-week randomized controlled trial.
Yoshikawa F, Kumashiro N, Shigiyama F, Uchino H, Ando Y, Yoshino H, Miyagi M, Ikehara K, Hirose T. Yoshikawa F, et al. Among authors: miyagi m. Diabetes Obes Metab. 2019 Feb;21(2):303-311. doi: 10.1111/dom.13524. Epub 2018 Oct 5. Diabetes Obes Metab. 2019. PMID: 30187632 Clinical Trial.
752 results